Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K R McCrae

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 1, 1994
Expression of urokinase receptors by human trophoblast. A histochemical and ultrastructural analysisH A Multhaupt, A Mazar, D B Cines, et al.
Hematology. American Society of Hematology. Education Program|November 28, 2001
Platelets: an update on diagnosis and management of thrombocytopenic disordersK R McCrae, J B Bussel, P M Mannucci, et al.
Blood|July 15, 1997
High molecular weight kininogen peptides inhibit the formation of kallikrein on endothelial cell surfaces and subsequent urokinase-dependent plasmin formationY Lin, R B Harris, W Yan, et al.
The Journal of Biological Chemistry|May 16, 2000
High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin IIK Ma, R Simantov, J C Zhang, et al.
The Journal of Biological Chemistry|November 21, 1998
The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor regulates cell surface plasminogen activator activity on human trophoblast cellsJ C Zhang, R Sakthivel, D Kniss, et al.
American Journal of Obstetrics and Gynecology|February 1, 1993
Plasma concentration of endothelin-1 in women with cocaine-associated pregnancy complicationsP Samuels, J D Steinfeld, L E Braitman, et al.
Immunopharmacology|June 1, 1997
Physical and biological significance of peptide sequences mediating the interaction between high molecular weight kininogen and plasma prekallikreinR W Colman, Y Lin, W Y Yan, et al.
Journal of Clinical Apheresis|August 10, 1999
Persistant pre-eclampsia post partum with elevated liver enzymes and hemolytic uremic syndromeK Mahalati, R B Dawson, J O Collins, et al.
The Journal of Clinical Investigation|September 18, 1997
Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptorR W Colman, R A Pixley, S Najamunnisa, et al.
The Journal of Biological Chemistry|June 5, 1988
Tissue-type plasminogen activator binding to human endothelial cells. Evidence for two distinct binding sitesE S Barnathan, A Kuo, H Van der Keyl, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 1, 1994
Expression of urokinase receptors by human trophoblast. A histochemical and ultrastructural analysisH A Multhaupt, A Mazar, D B Cines, et al.
Hematology. American Society of Hematology. Education Program|November 28, 2001
Platelets: an update on diagnosis and management of thrombocytopenic disordersK R McCrae, J B Bussel, P M Mannucci, et al.
Blood|July 15, 1997
High molecular weight kininogen peptides inhibit the formation of kallikrein on endothelial cell surfaces and subsequent urokinase-dependent plasmin formationY Lin, R B Harris, W Yan, et al.
The Journal of Biological Chemistry|May 16, 2000
High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin IIK Ma, R Simantov, J C Zhang, et al.
The Journal of Biological Chemistry|November 21, 1998
The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor regulates cell surface plasminogen activator activity on human trophoblast cellsJ C Zhang, R Sakthivel, D Kniss, et al.
American Journal of Obstetrics and Gynecology|February 1, 1993
Plasma concentration of endothelin-1 in women with cocaine-associated pregnancy complicationsP Samuels, J D Steinfeld, L E Braitman, et al.
Immunopharmacology|June 1, 1997
Physical and biological significance of peptide sequences mediating the interaction between high molecular weight kininogen and plasma prekallikreinR W Colman, Y Lin, W Y Yan, et al.
Journal of Clinical Apheresis|August 10, 1999
Persistant pre-eclampsia post partum with elevated liver enzymes and hemolytic uremic syndromeK Mahalati, R B Dawson, J O Collins, et al.
The Journal of Clinical Investigation|September 18, 1997
Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptorR W Colman, R A Pixley, S Najamunnisa, et al.
The Journal of Biological Chemistry|June 5, 1988
Tissue-type plasminogen activator binding to human endothelial cells. Evidence for two distinct binding sitesE S Barnathan, A Kuo, H Van der Keyl, et al.
Pageof 4